Date published: 2026-5-18

1-800-457-3801

SCBT Portrait Logo
Seach Input

6720489N17Rik Inhibitors

The class of "6720489N17Rik Inhibitors" encompasses a diverse range of chemical compounds, each with unique biochemical properties and mechanisms of action. While these compounds are not directly associated with 6720489N17Rik due to the lack of specific scientific data, they are known to modulate various cellular signaling pathways that could indirectly influence the activity of proteins encoded by this gene.

Compounds like PD98059, U0126, and SB203580 target specific components of the MAPK signaling pathway, such as MEK and p38 MAPK. This pathway is crucial for regulating cell proliferation, differentiation, and stress responses. By modulating these pathways, these inhibitors could potentially influence the activity or expression of proteins encoded by genes like 6720489N17Rik.

LY294002 and Wortmannin, both PI3K inhibitors, and Rapamycin, an mTOR inhibitor, are significant in affecting pathways related to cell growth, survival, and autophagy. The alteration of these pathways can have a downstream effect on proteins involved in these processes, including those encoded by 6720489N17Rik.

SP600125, a JNK inhibitor, plays a role in regulating apoptosis and other cellular stress responses, potentially affecting proteins involved in these pathways. EGFR inhibitors like Gefitinib and Erlotinib target key receptors involved in cell proliferation and apoptosis, thereby potentially influencing proteins in these signaling cascades.

Sorafenib, a multi-kinase inhibitor, and Dasatinib, a broad-spectrum tyrosine kinase inhibitor, exhibit diverse effects on cell proliferation, angiogenesis, and apoptosis pathways. Imatinib, known for its inhibition of BCR-ABL and other tyrosine kinases, also impacts cell proliferation and apoptosis.

These chemicals, through their varied actions, illustrate the complex interplay of cellular signaling and regulatory mechanisms. They represent a spectrum of biochemical tools that can modulate different aspects of cellular function, potentially influencing the activity of proteins similar to those encoded by 672048

9N17Rik. By acting at various levels, from gene expression to post-translational modifications, these inhibitors contribute to our understanding of the complex network of interactions within the cell.

Their diverse mechanisms of action highlight the intricate balance of cellular processes and offer a window into the potential regulation of proteins encoded by genes like 6720489N17Rik. Each compound, with its specific mode of action, provides insights into the dynamic nature of cell signaling pathways, showcasing how different biochemical interactions can influence protein activity.

In summary, the "6720489N17Rik Inhibitors" class represents a broad approach to understanding and modulating cellular signaling pathways. These compounds serve as valuable tools for research into the functional aspects of proteins and their role in various cellular processes. While direct inhibitors of 6720489N17Rik are not specified due to the lack of detailed information on the protein, this class of inhibitors presents a comprehensive method for exploring the modulation of protein activity within complex cellular networks.

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

MEK inhibitor, potentially influencing MAPK/ERK signaling pathways.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

p38 MAPK inhibitor, potentially affecting stress response and inflammatory pathways.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

PI3K inhibitor, potentially altering AKT signaling and related cellular processes.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

mTOR inhibitor, potentially influencing cell growth and autophagy pathways.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Another PI3K inhibitor, potentially affecting the PI3K/AKT signaling pathway.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

Specific inhibitor of MEK, potentially affecting the MAPK/ERK signaling pathway.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

JNK inhibitor, potentially influencing apoptosis and other cellular response pathways.

Gefitinib

184475-35-2sc-202166
sc-202166A
sc-202166B
sc-202166C
100 mg
250 mg
1 g
5 g
$63.00
$114.00
$218.00
$349.00
74
(2)

EGFR tyrosine kinase inhibitor, potentially affecting cell proliferation and apoptosis pathways.

Erlotinib Hydrochloride

183319-69-9sc-202154
sc-202154A
10 mg
25 mg
$75.00
$121.00
33
(1)

Another EGFR inhibitor, potentially influencing cell growth and survival signaling pathways.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

Multi-kinase inhibitor, potentially affecting cell proliferation, angiogenesis, and apoptosis pathways.